We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$27.7M
Cap. Flow
-$7M
Cap. Flow %
-0.26%
Top 10 Hldgs %
24.54%
Holding
474
New
12
Increased
115
Reduced
195
Closed
19

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.64M
2
MMM icon
3M
MMM
+$5.13M
3
CRM icon
Salesforce
CRM
+$4.32M
4
AMZN icon
Amazon
AMZN
+$3.46M
5
AVGO icon
Broadcom
AVGO
+$2.1M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$6.15M
2
GE icon
GE Aerospace
GE
+$3.4M
3
WFC icon
Wells Fargo
WFC
+$2.56M
4
IBM icon
IBM
IBM
+$2.39M
5
AGN
Allergan plc
AGN
+$1.76M

Sector Composition

Rank Sector Weight
1 Healthcare 14.59%
2 Financials 13.89%
3 Technology 12.64%
4 Industrials 11.12%
5 Consumer Staples 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$183B
$28.3M 1.05%
463,784
-122
-0% -$7.4K
IBM icon
27
IBM
IBM
$209B
$27.9M 1.03%
208,807
-17,103
-8% -$2.39M
MMM icon
28
3M
MMM
$90.8B
$27.1M 1%
164,498
+30,058
+22% +$5.13M
NKE icon
29
Nike
NKE
$62.7B
$26.8M 0.99%
336,689
-4,615
-1% -$325K
AVGO icon
30
Broadcom
AVGO
$1.85T
$26.8M 0.99%
1,105,350
+85,640
+8% +$2.1M
HON icon
31
Honeywell
HON
$76.7B
$26.8M 0.99%
205,969
+853
+0.4% +$113K
DHR icon
32
Danaher
DHR
$138B
$26.1M 0.97%
298,594
+152
+0.1% +$13.5K
ZTS icon
33
Zoetis
ZTS
$31.9B
$23.9M 0.89%
280,707
-1,763
-0.6% -$149K
SBUX icon
34
Starbucks
SBUX
$121B
$23.4M 0.87%
479,402
-15,485
-3% -$879K
MDLZ icon
35
Mondelez International
MDLZ
$80.5B
$22.9M 0.85%
558,882
+12,319
+2% +$495K
MRK icon
36
Merck
MRK
$321B
$22.8M 0.85%
394,498
+3,871
+1% +$218K
KO icon
37
Coca-Cola
KO
$381B
$21.5M 0.8%
489,820
-6,478
-1% -$280K
GOOGL icon
38
Alphabet (Google) Class A
GOOGL
$4.08T
$21.3M 0.79%
377,860
-12,960
-3% -$705K
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.1T
$21M 0.78%
112,605
-1,880
-2% -$366K
VZ icon
40
Verizon
VZ
$193B
$20.1M 0.75%
399,950
-1,926
-0.5% -$93.2K
MDY icon
41
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$19.3M 0.71%
54,254
+805
+2% +$283K
NVS icon
42
Novartis
NVS
$301B
$19M 0.71%
281,177
+3,441
+1% +$237K
UN
43
DELISTED
Unilever NV New York Registry Shares
UN
$18.8M 0.7%
337,052
+1,034
+0.3% +$57.8K
C icon
44
Citigroup
C
$222B
$18.3M 0.68%
274,198
+8,861
+3% +$610K
MKC icon
45
McCormick & Company Non-Voting
MKC
$13.7B
$18.1M 0.67%
311,828
-6,448
-2% -$339K
OXY icon
46
Occidental Petroleum
OXY
$55.6B
$17.5M 0.65%
209,288
+3,275
+2% +$262K
COST icon
47
Costco
COST
$423B
$17.1M 0.63%
81,881
-1,822
-2% -$360K
ALL icon
48
Allstate
ALL
$68.3B
$17.1M 0.63%
187,191
+3,055
+2% +$290K
KHC icon
49
Kraft Heinz
KHC
$31.3B
$17M 0.63%
271,341
-14,141
-5% -$839K
PFE icon
50
Pfizer
PFE
$142B
$16.9M 0.63%
491,787
-8,997
-2% -$307K

Similar funds

Gofen & Glossberg's Q2 2018 Portfolio in Review

As of Q2 2018, Gofen & Glossberg held 474 positions worth $2.7B, up 1% from $2.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gofen & Glossberg's Q2 2018 filing shows 12 new, 115 increased, 195 reduced and 19 closed positions. Its largest new stake was Evergy: 8,447 shares worth $474K. The largest sale was Monsanto Co, an estimated $6.15M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Gofen & Glossberg's largest Q2 2018 buy was Evergy: 8,447 shares worth $474K.
  • Gofen & Glossberg added most to DuPont de Nemours in Q2 2018, an estimated $6.64M increase.
  • Gofen & Glossberg's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $3.4M.
  • Gofen & Glossberg fully exited Monsanto Co in Q2 2018, selling an estimated $6.15M.
  • Gofen & Glossberg's ten largest holdings make up 25% of its $2.7B portfolio in Q2 2018.
  • Gofen & Glossberg opened 12 new positions and closed 19 in Q2 2018.
  • Gofen & Glossberg's portfolio value rose 1% quarter-over-quarter to $2.7B.

Based on Gofen & Glossberg's 13F filing for Q2 2018, filed 11 Jul 2018.